CROMA - PRINCESS - SAYPHA. IN 2019 CROMA PRINCESS BECOMES CROMA SAYPHA Founded in 1976, Croma-Pharma GmbH (Croma) is an Austrian family-owned company specializing in the industrial production of hyaluronic acid for the fields of aesthetic medicine, ophthalmology and orthopedics. Croma currently manages 12 international sales companies and distributes its products in more than 70 countries.
In its global sales network, Croma focuses on its own brand products for minimally invasive cosmetic medicine. In addition to a wide range of hyaluronic acid-based fillers from its own production site, Croma markets PDO tensor yarns, a Platelet Rich Plasma System (PRP) and customized skin care technology. within its core strategic markets.
Croma's range of hyaluronic acid fillers includes six products:
SAYPHA RICH, SAYPHA FILLER (with / without lidocaine), SAYPHA VOLUME (with / without lidocaine) and SAYPHA VOLUME PLUS Lidocaine.
SAYPHA RICH regenerates the loss of hyaluronic acid due to aging, improves hydration, skin tone and elasticity and corrects fine lines. The product is injected into the superficial dermal layer.
SAYPHA FILLER / SAYPHA FILLER Lidocaine corrects moderate to severe wrinkles and facial wrinkles and increases lip volume (only applicable for SAYPHA FILLER Lidocaine). The product is injected into the intermediate to deep dermis.
SAYPHA VOLUME / SAYPHA VOLUME Lidocaine have been developed to correct deeper wrinkles and wrinkles and to restore facial volume / reshape facial contours. The product is injected into the deeper skin layer (deep dermis or hypodermis).
SAYPHA VOLUME PLUS Lidocaine is used for facial tissue augmentation to correct lowering of the volume of the middle part of the face and to define the contours of the face as well as for reconstruction purposes, for example in the treatment of facial lipoatrophy. The product is injected subcutaneously, locally or in the deep dermis. All products are made from non-animal hyaluronic acid and are manufactured to the highest standards of quality and safety.
